Cargando...
Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer
Despite extensive efforts, there has been limited progress in optimizing treatment of ovarian cancer patients. The vast majority of patients experience recurrence within a few years despite a high response rate to upfront therapy. The minimal improvement in overall survival of ovarian cancer patient...
Guardado en:
| Publicado en: | Cancers (Basel) |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6562901/ https://ncbi.nlm.nih.gov/pubmed/31091744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11050668 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|